Annual Operating Profit
-$259.66 M
-$35.82 M-16.00%
31 December 2023
Summary:
Rocket Pharmaceuticals annual operaing income is currently -$259.66 million, with the most recent change of -$35.82 million (-16.00%) on 31 December 2023. During the last 3 years, it has fallen by -$93.41 million (-56.19%). RCKT annual operating profit is now -4339.37% below its all-time high of -$5.85 million, reached on 31 December 2012.RCKT Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$69.42 M
+$4.29 M+5.82%
30 September 2024
Summary:
Rocket Pharmaceuticals quarterly operating income is currently -$69.42 million, with the most recent change of +$4.29 million (+5.82%) on 30 September 2024. Over the past year, it has dropped by -$6.14 million (-9.71%). RCKT quarterly operating profit is now -4047.19% below its all-time high of -$1.67 million, reached on 31 December 2013.RCKT Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$273.79 M
-$4.00 M-1.48%
30 September 2024
Summary:
Rocket Pharmaceuticals TTM operating income is currently -$273.79 million, with the most recent change of -$4.00 million (-1.48%) on 30 September 2024. Over the past year, it has dropped by -$14.13 million (-5.44%). RCKT TTM operating profit is now -16255.44% below its all-time high of -$1.67 million, reached on 31 December 2013.RCKT TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCKT Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -9.7% | -5.4% |
| 3 y3 years | -56.2% | -58.4% | -64.7% |
| 5 y5 years | -242.1% | -253.3% | -260.7% |
RCKT Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -56.2% | at low | -63.1% | +5.8% | -64.7% | at low |
| 5 y | 5 years | -242.1% | at low | -253.3% | +5.8% | -260.7% | at low |
| alltime | all time | -4339.4% | at low | -4047.2% | +5.8% | <-9999.0% | at low |
Rocket Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$69.42 M(-5.8%) | -$273.79 M(+1.5%) |
| June 2024 | - | -$73.71 M(+9.4%) | -$269.80 M(+1.9%) |
| Mar 2024 | - | -$67.38 M(+6.5%) | -$264.84 M(+2.0%) |
| Dec 2023 | -$259.66 M(+16.0%) | -$63.28 M(-3.3%) | -$259.66 M(-2.0%) |
| Sept 2023 | - | -$65.43 M(-4.8%) | -$264.96 M(+2.7%) |
| June 2023 | - | -$68.76 M(+10.6%) | -$258.02 M(+6.0%) |
| Mar 2023 | - | -$62.19 M(-9.3%) | -$243.47 M(+8.8%) |
| Dec 2022 | -$223.84 M(+34.6%) | -$68.58 M(+17.3%) | -$223.84 M(+12.4%) |
| Sept 2022 | - | -$58.49 M(+7.9%) | -$199.09 M(+4.6%) |
| June 2022 | - | -$54.21 M(+27.4%) | -$190.25 M(+11.9%) |
| Mar 2022 | - | -$42.56 M(-2.9%) | -$170.09 M(+2.3%) |
| Dec 2021 | -$166.25 M(+23.8%) | -$43.83 M(-11.7%) | -$166.25 M(-8.5%) |
| Sept 2021 | - | -$49.65 M(+45.8%) | -$181.65 M(+14.0%) |
| June 2021 | - | -$34.05 M(-12.1%) | -$159.40 M(+7.0%) |
| Mar 2021 | - | -$38.72 M(-34.6%) | -$148.91 M(+10.9%) |
| Dec 2020 | -$134.30 M(+76.9%) | -$59.24 M(+116.3%) | -$134.30 M(+41.8%) |
| Sept 2020 | - | -$27.39 M(+16.2%) | -$94.72 M(+9.5%) |
| June 2020 | - | -$23.56 M(-2.3%) | -$86.49 M(+6.4%) |
| Mar 2020 | - | -$24.12 M(+22.8%) | -$81.33 M(+7.1%) |
| Dec 2019 | -$75.90 M | -$19.65 M(+2.5%) | -$75.90 M(-8.3%) |
| Sept 2019 | - | -$19.16 M(+4.2%) | -$82.80 M(+4.9%) |
| June 2019 | - | -$18.39 M(-1.6%) | -$78.97 M(+4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$18.70 M(-29.6%) | -$75.44 M(+6.3%) |
| Dec 2018 | -$70.97 M(+165.4%) | -$26.55 M(+73.1%) | -$70.97 M(+21.9%) |
| Sept 2018 | - | -$15.33 M(+3.1%) | -$58.24 M(+17.3%) |
| June 2018 | - | -$14.87 M(+4.6%) | -$49.63 M(+30.3%) |
| Mar 2018 | - | -$14.22 M(+2.9%) | -$38.09 M(+43.5%) |
| Dec 2017 | -$26.74 M(-36.2%) | -$13.81 M(+105.4%) | -$26.54 M(+6.3%) |
| Sept 2017 | - | -$6.72 M(+102.0%) | -$24.97 M(-13.8%) |
| June 2017 | - | -$3.33 M(+24.3%) | -$28.97 M(-15.8%) |
| Mar 2017 | - | -$2.68 M(-78.1%) | -$34.42 M(-17.8%) |
| Dec 2016 | -$41.88 M(+105.3%) | -$12.24 M(+14.1%) | -$41.88 M(+10.6%) |
| Sept 2016 | - | -$10.72 M(+22.1%) | -$37.87 M(+16.2%) |
| June 2016 | - | -$8.78 M(-13.4%) | -$32.58 M(+18.5%) |
| Mar 2016 | - | -$10.14 M(+23.2%) | -$27.48 M(+34.8%) |
| Dec 2015 | -$20.40 M(+164.7%) | -$8.23 M(+51.3%) | -$20.40 M(+46.9%) |
| Sept 2015 | - | -$5.44 M(+47.7%) | -$13.88 M(+31.8%) |
| June 2015 | - | -$3.68 M(+20.8%) | -$10.53 M(+16.5%) |
| Mar 2015 | - | -$3.05 M(+78.1%) | -$9.04 M(+17.4%) |
| Dec 2014 | -$7.70 M(+15.8%) | -$1.71 M(-17.9%) | -$7.70 M(+0.5%) |
| Sept 2014 | - | -$2.09 M(-4.9%) | -$7.67 M(+37.4%) |
| June 2014 | - | -$2.19 M(+28.2%) | -$5.58 M(+64.8%) |
| Mar 2014 | - | -$1.71 M(+2.3%) | -$3.39 M(+102.3%) |
| Dec 2013 | -$6.65 M(+13.8%) | -$1.67 M | -$1.67 M |
| Dec 2012 | -$5.85 M | - | - |
FAQ
- What is Rocket Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly operating profit year-on-year change?
- What is Rocket Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals TTM operating profit year-on-year change?
What is Rocket Pharmaceuticals annual operaing income?
The current annual operating profit of RCKT is -$259.66 M
What is the all time high annual operating profit for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high annual operaing income is -$5.85 M
What is Rocket Pharmaceuticals quarterly operating income?
The current quarterly operating profit of RCKT is -$69.42 M
What is the all time high quarterly operating profit for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high quarterly operating income is -$1.67 M
What is Rocket Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, RCKT quarterly operating income has changed by -$6.14 M (-9.71%)
What is Rocket Pharmaceuticals TTM operating income?
The current TTM operating profit of RCKT is -$273.79 M
What is the all time high TTM operating profit for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high TTM operating income is -$1.67 M
What is Rocket Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, RCKT TTM operating income has changed by -$14.13 M (-5.44%)